InterXion Gains Momentum and 3 Must-See Stock Analyses

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Molycorp, Inc. Common Stock (NYSE:MCP): JP Morgan continues to believe that  Molycorp, Inc. Common Stock will likely need to raise additional capital in early 2013. Following the company’s third quarter results, the firm keeps an Underweight rating on their stock with an $8 price target .

Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ): Following their third quarter results, Cowen believes that Jazz Pharmaceuticals, Inc. should be bought aggressively at current levels. The firm cited valuation and the belief that a generic launch of Xyrem will not occur before 2018, thus protecting their franchise. Shares are Outperform rated.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

InterXion Holding NV (NYSE:INXN): After the company reported slightly better than expected results, Wells Fargo raised their valuation range on InterXion Holding NV. The firm thinks that the company’s improved leasing trends indicate that its data centers expansion is gaining momentum. Wells maintains an Outperform rating on the stock.

Hasbro Inc. (NYSE:HAS): Despite speculation to the contrary, Needham believes it does not make sense for Disney (NYSE:DIS) to acquire Hasbro Inc. Needham said that Disney already reaps most of the benefits of sales from Disney-related toys through licensing arrangements. The firm keeps a Hold rating on shares of Hasbro.

Don’t Miss: What Do China’s Leadership Changes Mean for the Economy?

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business